Scan to Download
One power score. Smarter investment decisions
Xilio Therapeutics Inc
XLO0.780USD
+0.017+2.17%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
40.43MMarket Cap
LossP/E TTM
Xilio Therapeutics Inc
0.780
+0.017+2.17%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
Total revenue
242.98%8.08M
--2.93M
--1.72M
--2.26M
--2.36M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
242.98%8.08M
--2.93M
--1.72M
--2.26M
--2.36M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating expenses
31.82%22.45M
1.46%16.78M
-15.32%15.35M
-1.70%17.07M
-15.34%17.03M
-29.70%16.54M
-21.74%18.13M
-14.08%17.36M
-18.07%20.12M
10.85%23.53M
18.46%23.17M
26.60%20.21M
6.72%24.55M
28.47%21.22M
-5.04%19.56M
9.15%15.96M
100.99%23.01M
109.17%16.52M
--20.59M
--14.62M
--11.45M
--7.90M
R&D expenses
36.68%15.33M
-20.52%8.27M
-24.71%8.84M
-2.64%10.76M
-15.15%11.22M
-35.53%10.40M
-21.74%11.74M
-15.24%11.05M
-18.64%13.22M
8.12%16.13M
32.11%15.00M
24.53%13.04M
-8.45%16.25M
28.39%14.92M
-35.74%11.35M
-8.64%10.47M
94.00%17.75M
106.19%11.62M
--17.67M
--11.46M
--9.15M
--5.64M
Depreciation, depletion, and amortization
-10.11%400.00K
12.87%500.00K
-16.48%375.00K
-17.17%381.00K
-9.55%445.00K
-11.22%443.00K
-8.18%449.00K
-2.75%460.00K
10.56%492.00K
13.41%499.00K
24.11%489.00K
23.82%473.00K
19.30%445.00K
25.71%440.00K
15.54%394.00K
20.89%382.00K
34.66%373.00K
167.18%350.00K
--341.00K
--316.00K
--277.00K
--131.00K
Operating profit
2.10%-14.37M
16.25%-13.85M
24.83%-13.63M
14.73%-14.80M
27.05%-14.67M
29.70%-16.54M
21.74%-18.13M
14.08%-17.36M
18.07%-20.12M
-10.85%-23.53M
-18.46%-23.17M
-26.60%-20.21M
-6.72%-24.55M
-28.47%-21.22M
5.04%-19.56M
-9.15%-15.96M
-100.99%-23.01M
-109.17%-16.52M
---20.59M
---14.62M
---11.45M
---7.90M
Net non-operating interest income (expenses)
Non-operating interest expense
----
----
-100.00%0.00
----
----
-50.00%100.00K
-66.67%100.00K
0.00%200.00K
0.00%100.00K
0.00%200.00K
200.00%300.00K
--200.00K
--100.00K
--200.00K
-50.00%100.00K
----
----
----
--200.00K
----
----
----
Special income (expenses)
-66.67%-50.00K
100.00%0.00
--0.00
--41.00K
---30.00K
---948.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Other non-operating income (expenses)
-283.31%-1.43M
52.60%586.00K
-6.78%536.00K
-8.73%742.00K
-9.52%779.00K
-64.44%384.00K
-42.56%575.00K
31.98%813.00K
2107.69%861.00K
1421.13%1.08M
2324.44%1.00M
312.41%616.00K
122.41%39.00K
148.30%71.00K
-295.65%-45.00K
-47.96%-290.00K
-176.19%-174.00K
33.18%-147.00K
--23.00K
---196.00K
---63.00K
---220.00K
Income before tax
-13.78%-15.84M
22.89%-13.27M
25.84%-13.09M
16.29%-14.02M
28.05%-13.93M
24.04%-17.20M
21.41%-17.66M
15.37%-16.75M
21.36%-19.36M
-6.06%-22.65M
-14.03%-22.47M
-21.78%-19.79M
-6.18%-24.61M
-28.12%-21.35M
5.16%-19.70M
-9.66%-16.25M
-101.40%-23.18M
-105.31%-16.67M
---20.77M
---14.82M
---11.51M
---8.12M
Income after tax
-13.78%-15.84M
22.89%-13.27M
25.84%-13.09M
16.29%-14.02M
28.05%-13.93M
24.04%-17.20M
21.41%-17.66M
15.37%-16.75M
21.36%-19.36M
-6.06%-22.65M
-14.03%-22.47M
-21.78%-19.79M
-6.18%-24.61M
-28.12%-21.35M
5.16%-19.70M
-9.66%-16.25M
-101.40%-23.18M
-105.31%-16.67M
---20.77M
---14.82M
---11.51M
---8.12M
Net income from continuous operations
-13.78%-15.84M
22.89%-13.27M
25.84%-13.09M
16.29%-14.02M
28.05%-13.93M
24.04%-17.20M
21.41%-17.66M
15.37%-16.75M
21.36%-19.36M
-6.06%-22.65M
-14.03%-22.47M
-21.78%-19.79M
-6.18%-24.61M
-28.12%-21.35M
5.16%-19.70M
-9.66%-16.25M
-101.40%-23.18M
-105.31%-16.67M
---20.77M
---14.82M
---11.51M
---8.12M
Net income attributable to controlling interests
-13.78%-15.84M
22.89%-13.27M
25.84%-13.09M
16.29%-14.02M
28.05%-13.93M
24.04%-17.20M
21.41%-17.66M
15.37%-16.75M
21.36%-19.36M
-6.06%-22.65M
-14.03%-22.47M
-21.78%-19.79M
-6.18%-24.61M
-28.12%-21.35M
5.16%-19.70M
-9.66%-16.25M
-101.40%-23.18M
-105.31%-16.67M
---20.77M
---14.82M
---11.51M
---8.12M
Net income attributable to common shareholders
-13.78%-15.84M
22.89%-13.27M
25.84%-13.09M
16.29%-14.02M
28.05%-13.93M
24.04%-17.20M
21.41%-17.66M
15.37%-16.75M
21.36%-19.36M
-6.06%-22.65M
-14.03%-22.47M
-21.78%-19.79M
-6.18%-24.61M
-28.12%-21.35M
5.16%-19.70M
-9.66%-16.25M
-101.40%-23.18M
-105.31%-16.67M
---20.77M
---14.82M
---11.51M
---8.12M
Basic earnings per share
31.86%-0.16
71.19%-0.18
68.44%-0.20
63.70%-0.22
65.79%-0.24
25.34%-0.62
21.82%-0.64
15.75%-0.61
21.60%-0.70
-5.80%-0.83
-10.91%-0.82
-18.52%-0.72
-3.39%-0.90
-24.83%-0.78
5.16%-0.74
-9.66%-0.61
-101.40%-0.87
-105.31%-0.63
---0.78
---0.56
---0.43
---0.30
Diluted earnings per share
31.86%-0.16
71.19%-0.18
68.44%-0.20
63.70%-0.22
65.79%-0.24
25.34%-0.62
21.82%-0.64
15.75%-0.61
21.60%-0.70
-5.80%-0.83
-10.91%-0.82
-18.52%-0.72
-3.39%-0.90
-24.83%-0.78
5.16%-0.74
-9.66%-0.61
-101.40%-0.87
-105.31%-0.63
---0.78
---0.56
---0.43
---0.30
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
